Skip to content

Clinical trials

Phase 1/2 Mucopolysaccharidosis III trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Mucopolysaccharidosis III Phase: Phase 1/2 Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20113
20132
20152
20161
20171
20181
20192
20202
20232
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Terminated5
Active, not recruiting4
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alexion Pharmaceuticals, Inc.2
JCR Pharmaceuticals Co., Ltd.2
LYSOGENE2
Shire2
Swedish Orphan Biovitrum2
Abeona Therapeutics, Inc1
Allievex Corporation1
Denali Therapeutics Inc.1
Lynda E Polgreen1
NeuroGT1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Mucopolysaccharidosis III19
Genetic Diseases, Inborn4
Lysosomal Storage Diseases4
Metabolic Diseases4
Mucopolysaccharidoses3
Carbohydrate Metabolism, Inborn Errors2
Connective Tissue Diseases2
Metabolism, Inborn Errors2
Mucinoses2
Neurodegenerative Diseases2

Trials

Showing 26 to 19 of 19. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.